Management of Disease Modifying Interventions in Alzheimer's

Management of Disease Modifying Interventions in Alzheimer's

Discussion on indications, prescription, and management of adverse events associated with anti-amyloid therapy using monoclonal antibodies.

By The Neuro

Date and time

Tuesday, December 3 · 1 - 4:30pm GMT-5

Location

The Neuro, Montreal Neurological Institute – Hospital

3801 University Street de Grandpre Communications Centre Montréal, QC H3A 2B4 Canada

About this event

  • Event lasts 3 hours 30 minutes

The Management of Disease Modifying Interventions in Alzheimer's workshop, which will take place at The Neuro (Montreal Neurological Institute-Hospital), on December 3, 2024. This workshop is organized by Dr. Pedro Rosa-Neto, MD, PhD, from The Douglas Research Centre, McGill University, and The Neuro. The event will focus on discussing the indications, prescription, and management of adverse events associated with anti-amyloid therapy using monoclonal antibodies.

Our target audience includes researchers and professionals within the Alzheimer's community. The workshop will provide valuable insights into the latest treatment strategies and guidelines, aiming to equip healthcare professionals with the necessary tools to manage and prescribe anti-amyloid therapies effectively. Additionally, we aim to enhance the knowledge and skills required to handle adverse effects associated with these treatments.

Organized by